Reyhan Haider

Founder @ Health4US | ISEF '24 3rd Place | NJSHS 1st Place

Go Back

Reyhan Haider

Founder @ Health4US | ISEF '24 3rd Place | NJSHS 1st Place

Go Back

Bio

Bio

Reyhan Haider is an innovative researcher specializing in environmental science, chemical engineering, and materials science. His recent work has focused on developing eco-friendly, hybrid nanomaterials for sustainable water filtration, specifically targeting the removal of toxic heavy metals like lead from water sources. By engineering materials with high adsorption efficiency and reusability, Reyhan’s research aims to offer cost-effective, scalable solutions to global water contamination issues. His interdisciplinary approach, merging chemistry and environmental sustainability, highlights his commitment to practical applications in resource conservation. As a mentor, Reyhan provides guidance in materials science, environmental engineering, and project-based research, inspiring students to pursue impactful solutions to environmental challenges.

Reyhan Haider is an innovative researcher specializing in environmental science, chemical engineering, and materials science. His recent work has focused on developing eco-friendly, hybrid nanomaterials for sustainable water filtration, specifically targeting the removal of toxic heavy metals like lead from water sources. By engineering materials with high adsorption efficiency and reusability, Reyhan’s research aims to offer cost-effective, scalable solutions to global water contamination issues. His interdisciplinary approach, merging chemistry and environmental sustainability, highlights his commitment to practical applications in resource conservation. As a mentor, Reyhan provides guidance in materials science, environmental engineering, and project-based research, inspiring students to pursue impactful solutions to environmental challenges.

Fields Of Specialty

Fields Of Specialty

Biology

Biology

Biochemistry

Biochemistry

Biomedical and Health Science

Biomedical and Health Science

Biology

Biochemistry

Biomedical and Health Science

Past Projects

Past Projects

A Comprehensive LC-MS Metabolomics Approach Reveals a Novel Panel of Markers in an APOE4 Mouse Model of Alzheimer's Disease

Alzheimer’s disease affects millions worldwide, yet current FDA-approved drugs only provide symptomatic relief without effectively slowing its progression. APOE4 is the strongest genetic risk factor, with carriers at significantly higher risk of developing Alzheimer’s. This study investigates the molecular effects of APOE4 over time using an LC-MS untargeted metabolomic approach on cerebellum samples from E3 and E4 mice across various ages. Findings reveal 64 dysregulated metabolic features in 6-month-old E4 mice, with these markers also upregulated at 18 months, indicating persistent molecular disruption. Notably, female mice at 12 months displayed the most significant metabolic shifts, underscoring APOE4’s impact on vulnerable populations. This research aims to enhance understanding of APOE4’s role in Alzheimer’s, contributing to therapeutic advancements for at-risk individuals.

A Comprehensive LC-MS Metabolomics Approach Reveals a Novel Panel of Markers in an APOE4 Mouse Model of Alzheimer's Disease

Alzheimer’s disease affects millions worldwide, yet current FDA-approved drugs only provide symptomatic relief without effectively slowing its progression. APOE4 is the strongest genetic risk factor, with carriers at significantly higher risk of developing Alzheimer’s. This study investigates the molecular effects of APOE4 over time using an LC-MS untargeted metabolomic approach on cerebellum samples from E3 and E4 mice across various ages. Findings reveal 64 dysregulated metabolic features in 6-month-old E4 mice, with these markers also upregulated at 18 months, indicating persistent molecular disruption. Notably, female mice at 12 months displayed the most significant metabolic shifts, underscoring APOE4’s impact on vulnerable populations. This research aims to enhance understanding of APOE4’s role in Alzheimer’s, contributing to therapeutic advancements for at-risk individuals.